Weighing benefits and risks--the FDA's review of prasugrel

MeSH terms

• Angina, Unstable / drug therapy*
• Angioplasty, Balloon, Coronary*
• Aspirin / therapeutic use
• Cardiovascular Diseases / epidemiology
• Cardiovascular Diseases / mortality
• Causality
• Clinical Trials as Topic
• Combined Modality Therapy
• Coronary Thrombosis / prevention & control*
• Drug Administration Schedule
• Drug Therapy, Combination
• Hemorrhage / chemically induced*
• Humans
• Myocardial Infarction / drug therapy*
• Neoplasms / epidemiology
• Piperazines / adverse effects
• Piperazines / therapeutic use*
• Platelet Aggregation Inhibitors / adverse effects
• Platelet Aggregation Inhibitors / therapeutic use*
• Prasugrel Hydrochloride
• Thiophenes / adverse effects
• Thiophenes / therapeutic use*
• United States
• United States Food and Drug Administration